IGMS - IGM Biosciences Chief Commercial Officer discloses sale of 935 company shares
2023-10-04 11:11:30 ET
More on IGM Biosciences
- IGM Biosciences: What Causes The Very High Short Interest In This Ticker
- IGM Biosciences: High OpEx And Underwhelming Monotherapy Data Warrant Caution
- IGM Bioscience announces departure of chairman Michael Loberg
- Seeking Alpha’s Quant Rating on IGM Biosciences
- Historical earnings data for IGM Biosciences
For further details see:
IGM Biosciences Chief Commercial Officer discloses sale of 935 company shares